Visalytics
Visalytics
approved EB-2 (NIW)

Research Associate

Cell Biology · China · 2025-01-17

Processing Time
450 days
Decision Date
2025-01-17
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in cell biology, specifically focusing on cellular RNA processing, regulation, and RNA virus-host interactions. Her work utilizes biochemical assays, structural biology, and high-throughput chemical screening to identify novel antiviral targets and compounds against viruses such as SARS-CoV-2 and influenza A. The goal is to elucidate viral pathogenesis mechanisms to enable the development of next-generation antiviral therapies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research into viral pathogenesis and antiviral therapy development was found to have significant implications for U.S. and global health.

2 Well-positioned to Advance the Endeavor Met

The petitioner's extensive publication record, high citation count, and peer review experience demonstrate her leadership and capability in the field.

3 Waiver Benefit to the US Met

The urgency of developing antiviral treatments and the petitioner's unique expertise made it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 11 peer-reviewed journal articles in top-tier venues like Nature Communications and 929 citations from researchers in over 50 countries. Additionally, she completed 14 invited peer reviews and provided independent expert letters confirming her influence on antiviral screening and therapeutic development. These metrics satisfied all three prongs of the Dhanasar framework.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions

Similar Cases

Research Fellow

Biotechnology · Estonia

WeGreened EB-2 (NIW) approved
Maryland 36 days 2025-05-09
The petitioner proposes to continue her research in the field of biomedical sciences, specifically focusing on the development and characterization of antiviral therapeutics. She utilizes advanced molecular virology, multi-omics, and immune profiling techniques to unravel complex virus-host interactions. Her work aims to inform the creation of novel treatment approaches and improve existing virus mitigation strategies to enhance public health resilience.
View Case

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 5 days 2024-07-30
The petitioner proposes to continue researching viral pathogenesis and host-virus interactions to unravel the mechanisms of viral replication, transmission, and pathogenesis. This work aims to design vaccines, antiviral drugs, and diagnostic tools to combat viral threats and mitigate pandemics.
View Case

Postdoctoral Researcher

Biotechnology

WeGreened EB-2 (NIW) approved
Texas 26 days 2025-02-05
The petitioner proposes to continue investigating the molecular dynamics of viral replication and pathogenesis using model viral systems at a U.S. academic institution. This work focuses on exploring viral-host interactions and immune evasion strategies to facilitate the development of advanced vaccine platforms and targeted antiviral therapies. The endeavor aims to strengthen the United States' defense against viral epidemics and bioterrorism threats.
View Case

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 30 days 2025-06-07
The petitioner proposes to develop and apply advanced immunological and virological methodologies to investigate viral persistence and immune response mechanisms. The work specifically focuses on chronic diseases such as HIV and Epstein-Barr Virus (EBV) to advance therapeutic strategies and vaccine development. This research aims to lower disease burdens and improve public health outcomes by addressing infectious disease control.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-17.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 450 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist